| Literature DB >> 34879085 |
Leandro Zuccolotto Crivellenti1, Cristiane Alves Cintra2, Suellen Rodrigues Maia3, Gyl Eanes Barros Silva4, Sofia Borin-Crivellenti1, Rachel Cianciolo5, Christopher A Adin6, Mirela Tinucci-Costa2, Caio Santos Pennacchi1, Aureo Evangelista Santana2.
Abstract
Subclinical stage of ehrlichiosis is characterized by absence of clinical or laboratory alterations; however, it could lead to silent glomerular/tubular changes and contribute significantly to renal failure in humans and animals. The aim of this study was to evaluate glomerular and tubular alterations in dogs with subclinical ehrlichiosis. We evaluated renal biopsies of 14 bitches with subclinical ehrlichiosis and 11 control dogs. Samples were obtained from the left kidney, and the tissue obtained was divided for light microscopy, immunofluorescence, and transmission electron microscopy. Abnormalities were identified by light microscopy in 92.9% of dogs with ehrlichiosis, but not in any of the dogs of the control group. Mesangial cell proliferation and synechiae (46.1%) were the most common findings, but focal segmental glomerulosclerosis and ischemic glomeruli (38.4%), focal glomerular mesangial matrix expansion (30.7%), mild to moderate interstitial fibrosis and tubular atrophy (23%), and glomerular basement membrane spikes (23%) were also frequent in dogs with ehrlichiosis. All animals with ehrlichiosis exhibited positive immunofluorescence staining for immunoglobulins. Transmission electron microscopy from dogs with ehrlichiosis revealed slight changes such as sparse surface projections and basement membrane double contour. The subclinical phase of ehrlichiosis poses a higher risk of development of kidney damage due to the deposition of immune complexes.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34879085 PMCID: PMC8654155 DOI: 10.1371/journal.pone.0260702
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic, physical characteristics, and molecular and serological findings of the dogs selected in the study.
| GROUPS | ||
|---|---|---|
| Control (n = 11) | Ehrlichiosis (n = 14) | |
|
| 5.8 ± 3.4 | 5.3 ± 2.5 |
|
| 12.8 ± 17.2 | 14.7 ± 9.2 |
|
| female | female |
|
| Yes | Yes |
|
| ||
| Negative | Positive | |
| Negative | Negative | |
| Negative | Negative | |
|
| ||
|
| Negative | Positive (titers >1:320) |
| Leptospirosis | Negative | Negative |
Biochemical, urinary specific gravity, urine protein/creatinine ratio (UPC), systolic blood pressure (SBP) and hematological parameters (mean ± std deviation) of dogs from the control (n = 11) and ehrlichiosis group (n = 14).
| Reference intervals | GROUPS |
| ||
|---|---|---|---|---|
| Control | Ehrlichiosis | |||
| RBC count (x106/μL) | 5,5–8,4 | 6.37 ± 0.69 | 5.85 ± 1.58 | 0.9351 |
| Hemoglobin (g/dL) | 12–18 | 14.2 ± 1.7 | 13.3 ± 3.4 | 0.9701 |
| HCT (%) | 37–55 | 42 ± 4 | 39 ± 11 | 0.9658 |
| Leukocytes (x103/μL) | 6–18 | 8,782 ± 1,871 | 9,793± 5,769 | 0.4752 |
| Platelets (x103/μL) | 180–480 | 316.5 ± 72.3 | 283.2 ± 115.9 | 0.9053 |
| Total protein (g/L) | 5.4–7.1 | 5.9 ± 0.6 | 7.3 ± 0.9 | 0.0007 |
| Albumin (g/L) | 2.4–4.0 | 3.1 ± 0.4 | 2.7 ± 0.6 | 0.0242 |
| Globulin (g/L) | 2.7–4.4 | 2.8 ± 0.7 | 4.3 ± 1.2 | 0.0039 |
| Creatinine (mg/dL) | 0.5–1.4 | 1.0 ± 0.2 | 0.9 ± 0.1 | 0.0982 |
| Urea (mg/dL) | 15–65 | 27.7 ± 11.6 | 34.9 ± 15.1 | 0.2204 |
| Urinary Specific Gravity | 1.020–1.045 | 1.039 ± 0.01 | 1.032 ± 0.009 | 0.0319 |
| UPC | < 0.2 (Non-proteinuric) | 0.12±0.07 | 0.45±0.57 | 0.0215 |
| 0.2–0.5 (Borderline proteinuric) | ||||
| > 0,5 (Proteinuric) | ||||
| SBP (mmHg) | < 140.0 | 125.0 ± 13.85 | 132.2 ± 12.28 | 0.4375 |
| Findings glomerulotubular alterations | LM | Normal findings | Abnormalities in 92.9% | |
| IF | Negative | Positive in 100% | ||
| TEM | Normal findings | Abnormalities in 55.6% | ||
(*) Variables that show statistical differences.
Fig 1Light microscopy findings.
Control group: (A) Glomerular structure preserved, with no evidence of alterations. Masson’s Trichrome (x400). (B) Preserved glomerular structure, without evidence of alterations. Jones methenamine silver (JMS) (x630). Ehrlichiosis group: (C) Membranous-like glomerulopathy with diffuse and regular thickening of the glomerular capillary walls, frequently with mild and segmental mesangial proliferation. Masson’s trichrome (x400). (D) Synechia with evident segmental glomerulosclerosis (arrow). Masson’s Trichrome (x400). (E) Membranous-like glomerulopathy with sparse surface projections (spikes) along sub-epithelial surface of the glomerular basement membrane (arrow) (JMS) (x630).
Fig 2Immunofluorescence and transmission electron microscopy findings.
Control group: (A) Negative immunofluorescence. (x400). Ehrlichiosis Group: (B) Strong diffuse granular positivity for IgM in mesangium. (x400). (C) Electron microscopy evidencing sub-epithelial (arrow) and (D) sub-endothelial deposits (arrow) and capillary duplication of glomerular basement membrane (arrowhead) and effacement of the podocyte foot processes (dashed circle).
Relative distribution of the immunofluorescence intensity score in ehrlichiosis group.
The same animal may have been positive for more than one protein.
| Immunofluorescence Intensity Score | Ehrlichiosis group (n = 14) | |||
|---|---|---|---|---|
| IgG (n = 1) | IgA (n = 4) | IgM (n = 14) | C3 (n = 3) | |
| Weak | 100% | 75% | 21.4% | 66.6% |
| Moderate | 25% | 35.7% | ||
| Strong | 42.8% | 33.3% | ||